Valeant Pharmaceuticals International Inc (NYSE:VRX)

197.48
Delayed Data
As of Feb 27
 -3.77 / -1.87%
Today’s Change
106.00
Today|||52-Week Range
204.66
+37.99%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$65.9B

Company Description

Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology, and branded generics. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.

Contact Information

Valeant Pharmaceuticals International, Inc.
2150, St. Elzar boulevard Ouest
Laval Quebec H7L 4A8
P:(514) 744-6792
Investor Relations:
(949) 461-6002

Employees

Shareholders

Individual stakeholders8.36%
Other institutional53.85%
Mutual fund holders34.90%

Top Executives

J. Michael PearsonChairman & Chief Executive Officer
Howard Bradley SchillerChief Financial Officer, Director & Executive VP
Tage RamakrishnaChief Medical Officer
Jerzy JaneczkoHead-Information Technology
Susan T. HallSenior Vice President, Head-Research & Development

To view my watchlist

Not a member yet?

Sign up now for a free account